IL6 and neoplasm: 1Enhancing the ICD of tumor cells, improving the poor-immunogenicity2Reducing the proportion of MDSCs and its secretion IL-6/10, NO, ROS3Restoring the anti-cancer ability of CTLs4Inhibiting the expression of PD-L1